Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: A review.
Bugli F
Microbiol Res. 2022 Jul 30;263:127152. doi: 10.1016/j.micres.2022.127152
Synthetic recovery of impulse propagation in myocardial infarction via silicon carbide semiconductive nanowires.
Lagonegro P
Nat Commun. 2022 Jan 10;13(1):6. doi: 10.1038/s41467-021-27637-2
Biocompatible antimicrobial colistin loaded calcium phosphate nanoparticles for the counteraction of biofilm formation in cystic fibrosis related infections.
Iafisco M
J Inorg Biochem. 2022 Feb 5;230:111751. doi: 10.1016/j.jinorgbio.2022.111751
Modulation of LTCC Pathways by a Melusin Mimetic Increases Ventricular Contractility During LPS-Induced Cardiomyopathy.
Arina P
Shock. 2022 Mar 9;57(6):318-325. doi: 10.1097/SHK.0000000000001926
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.
Condorelli G
Proc Natl Acad Sci U S A. 99(19):12333-8.
MicroRNA-133 controls cardiac hypertrophy.
Carè A
Nat Med. 2007 Apr 29;13(5):613-8.
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure.
Gallo P
Cardiovasc Res. 2008 Aug 12;80(3):416-24. doi: 10.1093/cvr/cvn215
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability.
Catalucci D
J Cell Biol. 184(6):923-33. doi: 10.1083/jcb.200805063
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease.
Elia L
Cell Death Differ. 2009 Oct 9;16(12):1590-8. doi: 10.1038/cdd.2009.153
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions.
Elia L
Circulation. 2009 Nov 23;120(23):2377-85. doi: 10.1161/CIRCULATIONAHA.109.879429